SCHEDULE 13G/A: FMR LLC and Abigail P. Johnson Disclose 13.6% Stake in Pulmonx Corp
Beneficial Ownership Report
FMR LLC and its Chairman and CEO, Abigail P. Johnson, have jointly filed an amended Schedule 13G, disclosing a beneficial ownership of 13.6% of Pulmonx Corp's common stock as of March 31, 2025.
Summary
- FMR LLC, a Delaware-organized parent holding company, and Abigail P. Johnson, an individual, jointly reported beneficial ownership of 5,418,256 shares of Pulmonx Corp's common stock.
- This represents 13.6% of the total outstanding common stock of Pulmonx Corp.
- The filing is an Amendment No. 3 to a Schedule 13G, indicating an update to a previously reported ownership stake.
- FMR LLC holds sole voting power over 5,415,981 shares and sole dispositive power over 5,418,256 shares.
- Abigail P. Johnson, as Director, Chairman, and CEO of FMR LLC, is deemed to beneficially own the same aggregate amount of shares (5,418,256) due to her control relationship with FMR LLC.
- The shares are stated to be acquired and held in the ordinary course of business and not for the purpose of changing or influencing control of Pulmonx Corp.
Sentiment
Score: 5
Explanation: The document is a routine beneficial ownership disclosure (Schedule 13G Amendment), providing factual information about a significant institutional stake without expressing positive or negative sentiment about the issuer's performance or future.
Positives
- A major institutional investor, FMR LLC (Fidelity), maintains a significant 13.6% stake in Pulmonx Corp, which can be interpreted as continued confidence in the company.
- The filing explicitly states that the securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control, suggesting a passive investment.
Future Outlook
NA
Industry Context
NA
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Shareholder Voting Agreement | Members of the Johnson family, including Abigail P. Johnson, who are predominant owners of Series B voting common shares of FMR LLC (representing 49% of voting power), have entered into a shareholders' voting agreement. This agreement dictates that all Series B shares will be voted in accordance with the majority vote of Series B shares. | NA | This agreement centralizes voting power within the Johnson family for FMR LLC, which indirectly impacts the voting of shares held by FMR LLC, including those in Pulmonx Corp. It clarifies the control structure of the reporting entity, FMR LLC. |
Related Party Transactions
- The filing details that Abigail P. Johnson, as a Director, Chairman, and Chief Executive Officer of FMR LLC, and a member of the Johnson family (predominant owners of FMR LLC's voting shares), is deemed to beneficially own the same shares as FMR LLC. This highlights the control relationship between the individual and the reporting entity.
Stakeholder Impact
- Shareholders: Provides transparency regarding a significant institutional investor's stake (13.6%), which can influence market perception and potentially signal confidence or a long-term investment horizon from a major fund manager.
- Investment Professionals: Offers updated data on institutional ownership, crucial for tracking major holders and understanding market dynamics.
Key Dates
| Date | Description |
|---|---|
| 2023-01-03 | Effective date of Power of Attorney for Stephanie J. Brown on behalf of FMR LLC. |
| 2023-01-10 | Date of Schedule 13G filing by FMR LLC (accession number: -23-000003), referenced for Power of Attorney. |
| 2023-01-26 | Effective date of Power of Attorney for Stephanie J. Brown on behalf of Abigail P. Johnson. |
| 2023-01-31 | Date of Schedule 13G filing by FMR LLC (accession number: -23-000038), referenced for Power of Attorney. |
| 2025-03-31 | Date of event which requires filing of this statement (the date the ownership stake was determined). |
| 2025-05-09 | Date of filing of this Schedule 13G Amendment No. 3. |
Keywords
Pulmonx Corp, FMR LLC, Abigail P. Johnson, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, Fidelity, Shareholding, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.